Beth Reboussin to Mammography
This is a "connection" page, showing publications Beth Reboussin has written about Mammography.
Connection Strength
0.540
-
Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol. 2005 Nov 01; 162(9):826-34.
Score: 0.256
-
Crandall C, Palla S, Reboussin BA, Ursin G, Greendale G. Is there a positive association between mammographic density and bone mineral density? Authors' response. Breast Cancer Res. 2006; 8(2):404.
Score: 0.067
-
Crandall C, Palla S, Reboussin BA, Ursin G, Greendale GA. Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res. 2005; 7(6):R922-8.
Score: 0.064
-
Ursin G, Palla SL, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Greendale GA. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Clin Oncol. 2004 Jul 15; 22(14):2842-8.
Score: 0.059
-
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003 Jan 01; 95(1):30-7.
Score: 0.053
-
Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999 Feb 16; 130(4 Pt 1):262-9.
Score: 0.041